USPTO Proposes Rule to Recognize Client Privilege Extends to Patent Agents & Foreign Practitioners
On October 18, 2016, the United States Patent and Trademark Office (USPTO) published a proposed rule regarding recognition of privileged…
Read more
Third-Ever Post-Grant Review Decision Invalidates Patent Under § 101
Last week the Patent Trial and Appeal Board (PTAB) issued its third-ever Post-Grant Review (PGR) decision (PGR2015-00009), following the first…
Track One: USPTO’s Prioritized Patent Examination Program
OVERVIEW Fast innovation is a significant asset to competitiveness on the world stage. However, when a patent application is filed,…
USPTO Launches "Patents 4 Patients": A Cancer Immunotherapy Program
OVERVIEW The Cancer Immunotherapy Pilot Program (also known as “Patents 4 Patients”) provides accelerated review without requiring a petition fee…
USPTO Adds New Pilot Initiative That Could Help Move Pending Cases Through More Quickly – Combines Features of Pre-Appeal Conference & After-Final 2.0 Program
On July 11, the USPTO unveiled its Post-Prosecution Pilot Program (“P3”), which is scheduled to remain in effect until January…
BRI is Permissible Standard in IPR; USPTO Decisions to Institute IPR May Not Be Appealed
The Leahy-Smith America Invents Act (“AIA”) established the procedure of inter partes review (“IPR”) by which the USPTO may permit…